Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 1 de 1
Filter
Add more filters










Database
Language
Publication year range
1.
Article in English | MEDLINE | ID: mdl-28674053

ABSTRACT

We tested the activities of ceftolozane-tazobactam and 13 other antimicrobial agents against 221 strains of Burkholderia cepacia complex and Burkholderia gladioli Most strains (82%) were cultured from persons with cystic fibrosis, and most (85%) were recovered since 2011. The ceftolozane-tazobactam MIC was ≤8 µg/ml for 77% of the strains. However, the MIC range was broad (≤0.5 to >64 µg/ml; MIC50/90, 2/32 µg/ml). Significant differences in susceptibility to some antimicrobial agents were observed between species.


Subject(s)
Anti-Bacterial Agents/pharmacology , Burkholderia Infections/drug therapy , Burkholderia cepacia complex/drug effects , Burkholderia gladioli/drug effects , Cephalosporins/pharmacology , Penicillanic Acid/analogs & derivatives , beta-Lactamase Inhibitors/pharmacology , Burkholderia Infections/microbiology , Burkholderia cepacia complex/isolation & purification , Burkholderia gladioli/isolation & purification , Cystic Fibrosis/microbiology , Drug Combinations , Humans , Microbial Sensitivity Tests , Penicillanic Acid/pharmacology , Tazobactam
SELECTION OF CITATIONS
SEARCH DETAIL
...